Literature DB >> 33589648

Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.

Rui Wang1, Jiahui Chen1, Kaifu Gao1, Yuta Hozumi1, Changchuan Yin2, Guo-Wei Wei3,4,5.   

Abstract

pan class="Species">SARS-CoV-2 has been mutating since it was first sequenced in early January 2020. Here, we analyze 45,494 complete n>an class="Species">SARS-CoV-2 geneome sequences in the world to understand their mutations. Among them, 12,754 sequences are from the United States. Our analysis suggests the presence of four substrains and eleven top mutations in the United States. These eleven top mutations belong to 3 disconnected groups. The first and second groups consisting of 5 and 8 concurrent mutations are prevailing, while the other group with three concurrent mutations gradually fades out. Moreover, we reveal that female immune systems are more active than those of males in responding to SARS-CoV-2 infections. One of the top mutations, 27964C > T-(pan class="Mutation">S24L) on ORF8, has an unusually strong gender dependence. Based on the analysis of all mutations on the spike protein, we uncover that two of four SASR-CoV-2 substrains in the United States become potentially more infectious.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33589648      PMCID: PMC7884689          DOI: 10.1038/s42003-021-01754-6

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  34 in total

1.  Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0.

Authors:  Yves Dehouck; Aline Grosfils; Benjamin Folch; Dimitri Gilis; Philippe Bogaerts; Marianne Rooman
Journal:  Bioinformatics       Date:  2009-08-03       Impact factor: 6.937

2.  The I-TASSER Suite: protein structure and function prediction.

Authors:  Jianyi Yang; Renxiang Yan; Ambrish Roy; Dong Xu; Jonathan Poisson; Yang Zhang
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

3.  Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences.

Authors:  Jan Felix Drexler; Florian Gloza-Rausch; Jörg Glende; Victor Max Corman; Doreen Muth; Matthias Goettsche; Antje Seebens; Matthias Niedrig; Susanne Pfefferle; Stoian Yordanov; Lyubomir Zhelyazkov; Uwe Hermanns; Peter Vallo; Alexander Lukashev; Marcel Alexander Müller; Hongkui Deng; Georg Herrler; Christian Drosten
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.

Authors:  Ilona Glowacka; Stephanie Bertram; Marcel A Müller; Paul Allen; Elizabeth Soilleux; Susanne Pfefferle; Imke Steffen; Theodros Solomon Tsegaye; Yuxian He; Kerstin Gnirss; Daniela Niemeyer; Heike Schneider; Christian Drosten; Stefan Pöhlmann
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

5.  SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum.

Authors:  Kèvin Knoops; Marjolein Kikkert; Sjoerd H E van den Worm; Jessika C Zevenhoven-Dobbe; Yvonne van der Meer; Abraham J Koster; A Mieke Mommaas; Eric J Snijder
Journal:  PLoS Biol       Date:  2008-09-16       Impact factor: 8.029

6.  SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.

Authors:  Chun-Kit Yuen; Joy-Yan Lam; Wan-Man Wong; Long-Fung Mak; Xiaohui Wang; Hin Chu; Jian-Piao Cai; Dong-Yan Jin; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Kwok-Yung Yuen; Kin-Hang Kok
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

7.  SKEMPI 2.0: an updated benchmark of changes in protein-protein binding energy, kinetics and thermodynamics upon mutation.

Authors:  Justina Jankauskaite; Brian Jiménez-García; Justas Dapkunas; Juan Fernández-Recio; Iain H Moal
Journal:  Bioinformatics       Date:  2019-02-01       Impact factor: 6.937

8.  siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.

Authors:  T Li; Y Zhang; L Fu; C Yu; X Li; Y Li; X Zhang; Z Rong; Y Wang; H Ning; R Liang; W Chen; L A Babiuk; Z Chang
Journal:  Gene Ther       Date:  2005-05       Impact factor: 5.250

9.  GenBank.

Authors:  Dennis A Benson; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; Eric W Sayers
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

10.  Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine.

Authors:  Rui Wang; Yuta Hozumi; Changchuan Yin; Guo-Wei Wei
Journal:  J Chem Inf Model       Date:  2020-06-25       Impact factor: 4.956

View more
  51 in total

1.  Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.

Authors:  Francisco Barona-Gómez; Luis Delaye; Erik Díaz-Valenzuela; Fabien Plisson; Arely Cruz-Pérez; Mauricio Díaz-Sánchez; Christian A García-Sepúlveda; Alejandro Sanchez-Flores; Rafael Pérez-Abreu; Francisco J Valencia-Valdespino; Natali Vega-Magaña; José Francisco Muñoz-Valle; Octavio Patricio García-González; Sofía Bernal-Silva; Andreu Comas-García; Angélica Cibrián-Jaramillo
Journal:  Microb Genom       Date:  2021-11

Review 2.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

3.  Tracking the molecular evolution and transmission patterns of SARS-CoV-2 lineage B.1.466.2 in Indonesia based on genomic surveillance data.

Authors:  Mingjian Zhu; Qianli Zeng; Bryanna Infinita Laviashna Saputro; Sien Ping Chew; Ian Chew; Holie Frendy; Joanna Weihui Tan; Lanjuan Li
Journal:  Virol J       Date:  2022-06-16       Impact factor: 5.913

Review 4.  Update and Supplementary Articles Proteins of SARS CoV-2, Which Causes COVID-19, and the Interacting Proteins.

Authors:  Francis K Yoshimoto; Lawrence J Berliner
Journal:  Protein J       Date:  2021-05-21       Impact factor: 2.371

Review 5.  Prospects of Neutralizing Nanobodies Against SARS-CoV-2.

Authors:  Fangfang Chen; Zhihong Liu; Fan Jiang
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

6.  A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.

Authors:  Moses Effiong Ekpenyong; Mercy Ernest Edoho; Udoinyang Godwin Inyang; Faith-Michael Uzoka; Itemobong Samuel Ekaidem; Anietie Effiong Moses; Martins Ochubiojo Emeje; Youtchou Mirabeau Tatfeng; Ifiok James Udo; EnoAbasi Deborah Anwana; Oboso Edem Etim; Joseph Ikim Geoffery; Emmanuel Ambrose Dan
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

7.  Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.

Authors:  Austin N Spratt; Saathvik R Kannan; Lucas T Woods; Gary A Weisman; Thomas P Quinn; Christian L Lorson; Anders Sönnerborg; Siddappa N Byrareddy; Kamal Singh
Journal:  Comput Struct Biotechnol J       Date:  2021-06-24       Impact factor: 7.271

8.  A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.

Authors:  Eszter Somogyi; Zsolt Csiszovszki; Levente Molnár; Orsolya Lőrincz; József Tóth; Sofie Pattijn; Jana Schockaert; Aurélie Mazy; István Miklós; Katalin Pántya; Péter Páles; Enikő R Tőke
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

9.  Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System.

Authors:  Farooq Rashid; Muhammad Suleman; Abdullah Shah; Emmanuel Enoch Dzakah; Haiying Wang; Shuyi Chen; Shixing Tang
Journal:  Front Microbiol       Date:  2021-07-16       Impact factor: 5.640

Review 10.  SARS-CoV-2: is there neuroinvasion?

Authors:  Conor McQuaid; Molly Brady; Rashid Deane
Journal:  Fluids Barriers CNS       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.